A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Hebei Medical University Fourth Hospital
National Institutes of Health Clinical Center (CC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Alexandria University
Affiliated Hospital of Nantong University
Istanbul University - Cerrahpasa
Leuko Labs, Inc.
Dartmouth-Hitchcock Medical Center
Assistance Publique - Hôpitaux de Paris
GERCOR - Multidisciplinary Oncology Cooperative Group
UNC Lineberger Comprehensive Cancer Center
Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Soochow University
Thomas Jefferson University
University of Zurich
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Mario Negri Institute for Pharmacological Research
Augusta University
Spectrum Pharmaceuticals, Inc
Chang Gung Memorial Hospital
Poitiers University Hospital
Instituto Nacional de Cancerologia de Mexico
Kyowa Kirin Co., Ltd.
West Virginia University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
National Cancer Institute (NCI)
EVIVE Biotechnology
University of Nebraska
Universitaire Ziekenhuizen KU Leuven
Boston Children's Hospital
Duke University
Cairo University
Assiut University
Insel Gruppe AG, University Hospital Bern
EVIVE Biotechnology
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire de Nice
Aileron Therapeutics, Inc.
Rush University Medical Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Al-Azhar University
Fundació Sant Joan de Déu
Celgene
Celgene
University of Paris 13
National Institutes of Health Clinical Center (CC)
Spectrum Pharmaceuticals, Inc
Duke University